预测伤寒结合疫苗对抗菌药物耐药性的影响
研究采用确定性传播动态模型,模拟伤寒结合疫苗(TCV)对耐药伤寒感染及慢性携带者数量和比例的影响。模型显示提高疫苗接种覆盖率可减少耐药伤寒感染总数,但不改变耐药病例比例;在80%覆盖率下,35%的伤寒感染为耐药,10年内可避免44%的总病例。慢性携带者流行率、感染恢复率和耐药菌株相对适合度是影响预测的关键参数。
要点
- 提高TCV覆盖率可减少耐药伤寒感染总数,但不降低耐药病例比例。
- 80%覆盖率下,10年内可避免44%的总伤寒病例。
- 慢性携带者流行率、恢复率和耐药菌株适合度是关键影响因素。
核心结论
- 模型预测TCV可减少耐药伤寒感染总数和慢性携带者数量及比例,但耐药病例比例不变。
研究设计与样本
- 确定性传播动态模型,模拟TCV对耐药伤寒感染和慢性携带者的影响,并进行单因素敏感性分析。
主要发现
- 在80%疫苗接种覆盖率下,35%的伤寒感染为耐药,10年内可避免44%的总病例。
- 疫苗接种降低了耐药感染慢性携带者的总数和比例。
- 慢性携带者流行率、感染恢复率和耐药菌株相对适合度是影响耐药比例和避免病例数的关键参数。
关键数值与推荐
- 基础情景设定疫苗接种覆盖率为80%。
- 模型预测耐药感染比例和避免病例数强烈依赖于耐药菌株相对适合度、慢性携带者流行率和未治疗恢复率。
临床怎么用
- TCV接种可减轻抗菌药物选择压力,减少耐药伤寒感染总数。
- 需进一步明确耐药菌株适合度、慢性携带者流行率等参数以优化接种策略。
局限性
- 模型预测依赖于参数取值,需在真实伤寒流行区进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Empiric prescribing of antimicrobials in typhoid-endemic settings has increased selective pressure on the development of antimicrobial-resistant Salmonella enterica serovar Typhi. The introduction of typhoid conjugate vaccines (TCVs) in these settings may relieve this selective pressure, thereby reducing resistant infections and improving health outcomes. METHODS: A deterministic transmission dynamic model was developed to simulate the impact of TCVs on the number and proportion of antimicrobial-resistant typhoid infections and chronic carriers. One-way sensitivity analyses were performed to ascertain particularly impactful model parameters influencing the proportion of antimicrobial-resistant infections and the proportion of cases averted over 10 years. RESULTS: The model simulations suggested that increasing vaccination coverage would decrease the total number of antimicrobial-resistant typhoid infections but not affect the proportion of cases that were antimicrobial resistant. In the base-case scenario with 80% vaccination coverage, 35% of all typhoid infections were antimicrobial resistant, and 44% of the total cases were averted over 10 years by vaccination. Vaccination also decreased both the total number and proportion of chronic carriers of antimicrobial-resistant infections. The prevalence of chronic carriers, recovery rates from infection, and relative fitness of resistant strains were identified as crucially important parameters. CONCLUSIONS: Model predictions for the proportion of antimicrobial resistant infections and number of cases averted depended strongly on the relative fitness of the resistant strain(s), prevalence of chronic carriers, and rates of recovery without treatment. Further elucidation of these parameter values in real-world typhoid-endemic settings will improve model predictions and assist in targeting future vaccination campaigns and treatment strategies.
引用
- Kaufhold S, Yaesoubi R, Pitzer VE, et al. Predicting the Impact of Typhoid Conjugate Vaccines on Antimicrobial Resistance. Clin Infect Dis. 2019. PMID: 30845324. doi:10.1093/cid/ciy1108
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。